期刊文献+

IL-27基因转染对树突状细胞表型和功能的影响 被引量:1

Effects of IL-27 Gene Transfection on Phenotype and Function of Dendritic Cells
暂未订购
导出
摘要 目的探讨转染IL-27基因体外对人外周血单个核细胞来源树突状细胞表型和功能的影响。方法采集健康成人外周血,密度梯度离心法获得外周血单个核细胞,用GM-CSF、IL-4诱导树突状细胞(Dendritic cell,DC),第5天后将DC分为3组:IL-27基因转染组、TNF-α组和阴性对照组。倒置显微镜观察DC形态;流式细胞术检测DC表面分子CD1a、CD80、CD83和CD86的表达情况;MTT法检测DC刺激T细胞增殖的能力;ELISA法检测细胞培养上清中IL-12和IFN-γ的含量。结果转染IL-27基因后外周血单个核细胞来源DC呈现典型的成熟DC形态学特征。IL-27基因转染组DC表面CD1a、CD80、CD83和CD86表达水平较阴性对照组均明显上调(P<0.05)。IL-27基因转染组DC诱导T细胞增殖的能力较对照组DC明显增高(P<0.05)。IL-27基因转染组DC培养上清中IL-12和IFN-γ的含量均明显高于对照组DC(P<0.01)。结论转染IL-27基因可以上调成熟DC的细胞表型,增强DC的免疫学活性。 Objective To investigate the effects of IL-27 gene on phenotype and function of DCs(Dendritic cell) derived from PBMCs(peripheral blood mononuclear cells).Methods PBMCs isolated from healthy human peripheral blood were cultured with GM-CSF(granulocyte-macrophage clone stimulating factor)plus IL(Interleukin)-4 for 5 days,and then were divided into three groups:IL-27 gene transfection,TNF(tumor necrosis factor)-α and control group.The morphological characteristics of DCs were observed by inverted microscope.Expressions of CD1a,CD83 and CD80,and CD86 on DCs were analyzed with flow cytometry.MTT method was used to determine the proliferation of T cells stimulated by DCs.ELISA was used to detect the production of IL-12 and IFN-γ in the culture supernatant of DCs.Results PBMCs were developed into mature DCs with typical morphological characteristics after IL-27 gene transfection.Expressions of CD1a,CD83 and CD80,and CD86 on DCs in IL-27 gene transfection and TNF-α groups were up-regulated compared to the control group(P0.05).IL-27 gene transfected DCs markedly stimulated the proliferation of T cells and enhanced the production of IL-12 and IFN-γ(P0.05).Conclusion IL-27 gene transfection could up-regulate the phenotype of mature DCs and enhance the immune activity of DCs.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第1期31-34,共4页 Cancer Research on Prevention and Treatment
基金 河北省科技厅基金资助项目(10276105D-98) 河北省卫生厅基金资助项目(20100413)
关键词 白细胞介素27 树突状细胞 细胞培养 免疫活性 Interleukin-27 Dendritic cells Cells culture Immune activity
  • 相关文献

参考文献12

  • 1Pflanz S, Timans JC, Cheung J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells[J]. Immunity, 2002, 16(6): 779- 790.
  • 2Owaki T, Asakawa M, Morishima N, et al. A Role for IL-27 in early regulation of Thl differentiation [J]. J Immunol, 2005, 175(4) : 2191-2200.
  • 3Sakai Y, Morrison BJ, Burke JD,et al. Vaccination by genetically modified dendritic cells expressing a truncated neu onco gene prevents development of breast cancer in transgenic mice [J].Cancer Res, 2004, 64(21 ):8022-8028.
  • 4Haining WN, Davies J, Kanzler H, et al. CpG oligodeoxy nucleotides alter lymphocyte and dendritic cell trafficking in humans[J]. Clin Cancer Res, 2008, 14(17): 5626 5634.
  • 5Redman BG, Chang AE, Whitfield J, et al. Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma[J]. J lmmunother, 2008, 31 (6) : 591-598.
  • 6Cao DY, Yang JY, Dou KF, et al. Alpha-fetoprotein and interleukin-18 gene-modified dendritic cells effectively stimulate specific type-1 CD4- and CD8-mediated T-Cell response from hepatocellular carcinoma patients in vitro [J]. Hum Immunol, 2007, 68(5): 334-341.
  • 7Yang JY, Cao DY, Liu WC, et al. Dendritic cell generated from CD34 + hematopoietic progenitors can be transfeeted with adenovirus containing gene of HBsAg and induce antigenspecific cytotoxic T cell responses[J]. Cell Immunol, 2006, 240(1): 14-21.
  • 8Kim GY, Chae HJ. blim KH, et al. Dendritic cell-tumor fusion vaccine prevents tumor growth in vivo [J]. Biosci Biotechnol Biochem, 2007, 71 (1): 215-221.
  • 9Prechtel AT, Steinkasserer A. CD83: an update on functions and prospects of the maturation marker of dendritic cells[J]. Arch Dermatol Res, 2007, 299(2): 59-69.
  • 10Piccioli D, Sbrana S, Melandri E, et al. Contact dependent stimulation and inhibition of dendritic cells by natural killer cells[J]. J Exp Med, 2002, 195(3) :335-341.

同被引文献36

  • 1Yoshimoto T, Chiba Y, Furusawa J, et al. Potential clinical application of interleuldn-27 as an antitumor agent [ J]. Cancer Sci, 2015, 106(9) : 1103 - 1110.
  • 2Wang H, Meng R, Li Z, et al. IL-27 induces the differentiation of Trl-like cells from human naive CD4^+ T cells via the phosphorylation of STAT1 and STAT3 [J]. Immunol Lett, 2011, 136(1) : 21 -28.
  • 3Hisada M, Kamiya S, Fujita K, et al. Potent antitumor activity of intedeukin-27[ J]. Cancer Res, 2004, 64(3) : 1152 - 1156.
  • 4Xia S, Wei J, Wang J, et al. A requirement of dendritic cell-derived interleukin-27 for the tumor infiltration of regulatory T cells [ J ]. J Leukoc Biol, 2014, 95(5) : 733 -742.
  • 5Shin-au M, SY M, Owaki T, et al. Antiangiogenic and antitumor activities of IL-27 [ J ]. J Immunol, 2006, 176 (12) : 7317 - 7324.
  • 6Cui W, Liu Y, Weinstein J S, et al. An interleukin-21-interleukin-10- STAT3 pathway is critical for functional maturation of memory CD8 + T cells[J]. Immunity, 2011, 35(5) : 792 -805.
  • 7Stulader J S, I-hinter C A. Advances in understanding the anti-inflarma properties of IL-27 [J]. Immunol Lett, 2008, 117(2) : 123 -130.
  • 8Vignali D A, Kuchroo V K. IL-12 family cytokines: immunological playmakers[J]. Nat Immunol, 2012, 13(8) : 722 -728.
  • 9Bosmann M, Ward P A. Modulation of inflammation by interleukin-27 [J]. J Leukoc Biol, 2013, 94(6) : 1159 -1165.
  • 10Li Q, Sate A, Shimozato O, et al. Administration of DNA encoding the interleukin-27 gene augments anti-tumor responses through non-adaptive immunity [ J ]. Scand J Immunol, 2015, 82 ( 4 ) : 320 - 327.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部